by Sam Collins | August 9, 2013 4:15 am
I first recommended Gilead Sciences (GILD) back on Nov. 19, when the stock was trading at $37.50 after a gap higher. That move established a bull trend that only recently has been subject to profit-taking.
GILD is up 60% from our initial buy-point. Investors who bought in November should protect their positions by writing calls or buying puts. Any weakness in the stock that results in a pullback to its 50-day moving average — around $55 — should be used to buy new shares. My long-term target for Gilead is $70.
Source URL: http://investorplace.com/2013/08/gilead-is-going-higher-yet/
Short URL: http://investorplace.com/?p=385397
Copyright ©2013 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.